Results 31 to 40 of about 19,681 (244)
British Journal of Pharmacy, 2023 Exocrine pancreatic insufficiency (EPI) is caused by insufficient secretion or limited activity of pancreatic enzymes, especially lipase. Chronic pancreatitis (CP) is the most common EPI disease.
Tânia Martins Garcia +3 more
doaj +1 more source
Вопросы современной педиатрии, 2013 One of the complications of diabetes mellitus is the development of pancreatic exocrine insufficiency. Fecal elastase 1 is a good marker of pancreatic exocrine secretion.
A. A. Nizhevich +4 more
doaj +1 more source
Enzyme Replacement Therapy in the Pancreatic Duct Ligated Swine
Experimental Biology and Medicine, 1972 SummaryPancreatic duct ligation (PDL) in swine reduced absorption of dietary fat and protein to less than 50%. Supplementation of the diet with pancreatin 4X NF at 0.1, 0.5 and 1.0% resulted in a significant improvement in fat absorption which approached normal on the highest level of pancreatin.
A R, Imondi, R P, Stradley, R, Wolgemuth
openaire +2 more sources
Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer
PharmacyMost patients with pancreatic cancer at some point present with symptoms related to exocrine pancreatic insufficiency (EPI). These include diarrhea, abdominal bloating, indigestion, steatorrhea, weight loss, and anorexia.
Mary Acelle G. Garcia +3 more
doaj +1 more source
Gastroenterologìa, 2015 The article deals with exocrine pancreatic insufficiency (EPI), which is being detected in a significant number (30–50 %) of patients with diabetes mellitus (DM) type I and II and could potentially affect the compensation of DM.
S.M. Tkach
doaj +1 more source
Arquivos de GastroenterologiaBackground - Among late postoperative complications of pancreatectomy are the exocrine and endocrine pancreatic insufficiencies. The presence of exocrine pancreatic insufficiency imposes, as standard treatment, pancreatic enzyme replacement.
Anna Victoria FRAGOSO +3 more
doaj +1 more source
Pancreatic enzyme replacement therapy after gastric resection: An update [PDF]
Digestive and Liver Disease, 2018 Exocrine pancreatic insufficiency (EPI) is one of the possible mechanisms of fat maldigestion following gastric surgery, together with reduced food intake, loss of gastric reservoir, small bowel bacterial overgrowth and rapid small bowel transit. Oral pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment for EPI.
Filippo, Antonini +4 more
openaire +2 more sources
Neonatal diabetes mellitus – manifestation of GATA-6 syndrome [PDF]
Romanian Journal of PediatricsGATA6 syndrome is an unusual genetic disorder that presents complications during pregnancy, congenital heart defects, neonatal diabetes, and severe pancreatic dysfunction.
Galina Gorbunov +2 more
doaj +1 more source
Pancreatic enzyme replacement therapy for young cystic fibrosis patients [PDF]
Journal of Cystic Fibrosis, 2009 Maldigestion in cystic fibrosis (CF) affects approximately 90% of patients. As soon as pancreatic insufficiency is identified, enzyme supplementation is prescribed even with breast fed infants. A pancreatic enzyme preparation developed particularly for infants, Creon for children (CfC), contains smaller granules to be administered with a dosing spoon ...
Munck, Anne +15 more
openaire +2 more sources
Molecular Oncology, EarlyView.The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source